Inozyme Pharma (NASDAQ:INZY) Downgraded by Zacks Investment Research to Hold

Inozyme Pharma} stock has undergone multiple analysts rating changes in the recent past.  Inozyme Pharma Downgraded by Zacks Investment Research on 10/14/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Inozyme Pharma (NASDAQ:INZY) Downgraded by Zacks Investment Research to Hold

PhenixFIN (INZY) Upgraded by Zacks Investment Research to Hold

PhenixFIN} stock has undergone multiple analysts rating changes in the recent past.  PhenixFIN Upgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Strong Sell.

View More PhenixFIN (INZY) Upgraded by Zacks Investment Research to Hold